Jan Pinkas

Dr. Jan Pinkas is the Chief Scientific Officer of Pyxis Oncology. Prior to joining Pyxis Oncology, Jan was Senior Vice President, Head of Translational Sciences at Magenta Therapeutics where he was responsible for all therapeutic programs from development candidate nomination through Phase II with particular focus on toxicology, clinical pharmacology, and biomarkers. Prior to this role, Jan worked at ImmunoGen as Vice President, Translational Research & Development where he led nonclinical and translational research and development related activities in discovery through late stage clinical development. He obtained his Ph.D. in Molecular and Cellular Biology from the University of Massachusetts at Amherst and his undergraduate degree in biology from Johns Hopkins University.